1119PDInducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)
Rischin, D, Groenland, S L, Lim, A M L, Martin-Liberal, J, Moreno, V, Trigo Perez, J M, Le Tourneau, C, Mathew, M, Cho, D C, Hansen, A R, Vincente-Baz, D, Maio, M, Italiano, A, Bauman, J R, Chisamore,Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.011
Date:
October, 2019
File:
PDF, 94 KB
2019
File converter
More search results
More benefits 
